These IDO1+ EVs derived from IFN-γ exposed GBM cells lead to higher induction of MDSCs from monocytes and cause more T cell inhibition compared to EVs derived from IFN-γ naïve GBM cells that have lower IDO1 expression (43). The gene discussed is IDO1; the disease is glioblastoma.